Quick Answer
Edesa Biotech, Inc. reported Total Assets of $13.53 million for fiscal year 2025.
Edesa Biotech, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $13.53M | +254.8% |
| 2024 | $3.81M | -57.1% |
| 2023 | $8.89M | -23.2% |
| 2022 | $11.58M | -20.6% |
| 2021 | $14.58M | +35.5% |
| 2020 | $10.76M | +88.2% |
| 2019 | $5.72M | -51.5% |
| 2018 | $11.78M | +52.6% |
| 2017 | $7.72M | -40.3% |
| 2016 | $12.94M | +24.6% |
| 2015 | $10.39M | -30.0% |
| 2014 | $14.83M | +2.4% |
| 2014 | $14.47M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $14.71M | +253.3% | +8.7% |
| September 30, 2025 | $13.53M | +254.8% | -8.6% |
| June 30, 2025 | $14.80M | +183.2% | -10.0% |
| March 31, 2025 | $16.45M | +154.1% | +295.1% |
| December 31, 2024 | $4.16M | -46.8% | +9.2% |
| September 30, 2024 | $3.81M | -57.1% | -27.0% |
| June 30, 2024 | $5.23M | -44.5% | -19.3% |
| March 31, 2024 | $6.48M | -39.3% | -17.3% |
- Edesa Biotech, Inc. showed an increase of +254.8% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, Edesa Biotech, Inc.’s total assets has declined by 6.5% (from $14.47 million to $13.53 million).
- The most recent figure is from Edesa Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 12, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: